Cimenga Tshibaka v. John Sernulka

673 F. App'x 272
CourtCourt of Appeals for the Fourth Circuit
DecidedDecember 13, 2016
Docket15-1839
StatusUnpublished
Cited by3 cases

This text of 673 F. App'x 272 (Cimenga Tshibaka v. John Sernulka) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cimenga Tshibaka v. John Sernulka, 673 F. App'x 272 (4th Cir. 2016).

Opinion

Unpublished opinions are not binding precedent in this circuit,

PER CURIAM:

Cimenga M. Tshibaka, a Maryland physician, appeals from the district court’s rulings that dispensed with a civil suit concerning the termination of his hospital privileges. Tshibaka, who had privileges at Carroll Hospital Center, Inc. (“CHC”), in Westminster, Maryland, was accused of sexual harassment by a patient care technician. After CHC terminated Tshibaka’s privileges, he initiated litigation in state court against the patient care technician, CHC, and its CEO. The complaint alleged a race discrimination claim under 42 U.S.C. § 1981, plus various state law claims. The defendants removed the matter to the District of Maryland, where the court dismissed the patient care technician and awarded summary judgment to CHC and its CEO. Tshibaka has appealed, and as explained below, we affirm in part, vacate in part, and remand.

I.

A.

1.

Dr. Tshibaka, who is African-American, is a native of the Democratic Republic of the Congo and a naturalized citizen of the United States. 1 [Redacted]. Tshibaka thereafter completed a residency in car-diothoracic surgery at the University of Illinois.

In 2005, Tshibaka sought to join the medical staff at CHC. During the credentialing process, [Redacted]. On April 11, 2006, CHC granted Tshibaka unrestricted hospital privileges.

Tshibaka’s tenure at CHC proceeded without incident until October 2008, [Redacted].

*274 [Redacted].

On March 15, 2010, Sernulka and Tshi-baka executed an Early Resolution Agreement. Pursuant thereto, Tshibaka agreed to apologize to the nurse, undergo a'mental health evaluation, and begin treatment. The Early Resolution Agreement also contained a last chance provision:

[Redacted] 2

See J.A. 468. By the Early Resolution Agreement, Tshibaka waived certain of his rights under CHC’s Medical Staff Bylaws (the “M.S. Bylaws”).

Shortly thereafter, pursuant to the Early Resolution Agreement, CHC hired two experts—clinical sexologists Kate Thomas and Chris Kraft—to evaluate Tshibaka. The expert report concluded that Tshibaka was a safe medical practitioner who posed no danger to the staff or patients at CHC. The report found that, although Tshibaka did not have a sexual disorder, his interpersonal skills were occasionally deficient. It recommended that Tshibaka undergo monthly individual psychotherapy sessions. By mutual agreement, those sessions were conducted by Thomas. On March 28, 2011, Thomas advised CHC that she was discharging Tshibaka as her patient because he had completed the recommended therapy-

On June 24, 2013, defendant Jaime Elliott was working as a patient care technician in CHC’s Wound Care Center. Tshi-baka routinely worked at the Wound Care Center on Monday afternoons and often interested with Elliot. [Redacted]. For his part, Tshibaka maintains that Elliott fabricated each of the foregoing instances of [Redacted].

2.

On June 25, 2013, Elliott lodged an internal sexual harassment complaint. CHC’s Vice President of Human Resources, Tracey Ellison, and Chief Compliance Officer, Joyce Romans, promptly investigated Elliott’s complaint pursuant to the hospital’s Medical Staff Conduct Policy (the “M.S. Conduct Policy”). In them investigation, they interviewed Elliott, her supervisors, and her co-workers. Romans and Ellison shared the evidence with CEO Sernulka, who found Elliott’s complaint to be credible. Sernulka thus concluded that Tshibaka had violated the last chance provision of the Early Resolution Agreement. Later that day,- Sernulka decided to terminate Tshibaka’s hospital privileges at CHC. To that end, he issued a Determination of Probable Cause, which precipitated two interrelated processes: (1) a summary suspension process; and (2) a merits hearing. 3

Pursuant to the M.S. Bylaws, a summary suspension of a CHC staff member is warranted when “the conduct or condition of the Member presents an immediate threat of danger to any patient, other practitioner, Hospital personnel or visitor.” See M.S. Bylaws § 10.2.1.2. 4 Conduct meriting a summary suspension includes sexual harassment, which is defined in the M.S. Bylaws as “[u]nwelcome sexual advances, requests for sexual favors, and other verbal or physical conduct of a sexual nature” when “[s]uch conduct has the purpose or effect of unreasonably interfering with an *275 individual’s work performance or creating an intimidating, hostile or offensive work environment.” Id. §§ 10.3.1, 10.3.1.3. The summary suspension process begins when the CEO determines, in relevant part, that there is probable cause to believe that sexual harassment occurred. Id. § 10.3.2.1.

First, the CEO is empowered to impose a summary suspension. See M.S. Bylaws § 10.3.2.1.1. If a summary suspension is imposed, CHC’s Medical Executive Committee (the “MEC”) is obliged to review the suspension within four days and recommend that it be continued, modified, or terminated. Id. § 10.2.3.1. The MEC notifies the suspended physician of its decision and his right to review by the Board of Directors (the “Board”). Id. § 10.2.3.2.1. Finally, the suspended physician may submit a written request for Board review within seven business days of notification. Id. § 10.2.3.2.2. If requested, the Board reviews the MEC’s decision and decides whether it is justified. Id. § 10.2.3.5.

In this situation, CEO Sernulka issued the Determination of Probable Cause on June 25, 2013, relating therein that Tshiba-ka had sexually harassed Elliott and violated the Early Resolution Agreement. Ser-nulka also decided to summarily suspend Tshibaka and promptly advised him of that decision. According to Tshibaka, Sernulka stated that he was “not interested” in hearing Tshibaka’s side of the story and warned Tshibaka to get a good attorney because he would never practice medicine again. See J.A. 672.

On June 26, Sernulka notified the Medical Staff President (the “M.S. President”) of Tshibaka’s summary suspension. Sernul-ka advised Tshibaka that the MEC would review his suspension within four days and that he would be promptly informed of the MEC’s decision. On June 27, the MEC voted to continue Tshibaka’s summary suspension. Sernulka notified Tshibaka the following day of the MEC’s decision and his right to appeal to the Board. 5 Tshibaka requested Board review, and on July 2, the Board voted to continue his summary suspension.

b.

Simultaneous with the summary suspension process, CEO Sernulka also pursued the second process—a merits hearing— seeking to terminate Tshibaka’s hospital privileges. To obtain a merits hearing, the CEO of CHC issues a probable cause determination and provides written notice to the accused physician, the M.S. President, and the Board. See M.S. Bylaws § 10.3.2. Within three days of receiving the CEO’s written notice, the M.S.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
673 F. App'x 272, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cimenga-tshibaka-v-john-sernulka-ca4-2016.